Company profile for BioCryst Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. BioCryst has its headquarters in Durham, North Carolina and its Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development, and regulatory affairs, we are advancing clinical programs and generating new compounds from our own discovery engine....
BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. BioCryst has its headquarters in Durham, North Carolina and its Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development, and regulatory affairs, we are advancing clinical programs and generating new compounds from our own discovery engine. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4505 Emperor Blvd., Suite 200 Durham, NC 27703
Telephone
Telephone
(919) 859-1302
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/06/3182536/29446/en/BioCryst-Presents-New-Data-at-ACAAI-Highlighting-Burden-of-HAE-on-Pediatric-Patients-and-Caregivers-and-Sustained-Reduction-of-Attacks-in-Children-Treated-with-One-Year-of-ORLADEYO.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181273/29446/en/BioCryst-to-Present-at-Upcoming-Investor-Conference.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181314/29446/en/BioCryst-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/23/3171899/29446/en/BioCryst-to-Present-New-Pediatric-HAE-Data-at-the-American-College-of-Allergy-Asthma-Immunology-2025-Annual-Scientific-Meeting.html

GLOBENEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/20/3169233/29446/en/BioCryst-to-Report-Third-Quarter-2025-Financial-Results-on-November-3.html

GLOBENEWSWIRE
20 Oct 2025

https://www.fiercebiotech.com/biotech/biocryst-inks-700m-astria-buyout-challenge-takeda-rare-disease-market

FIERCE BIOTECH
14 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact BioCryst Pharmaceuticals and get a quotation

BioCryst Pharmaceuticals is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Peramivir bulk offered by BioCryst Pharmaceuticals

Find a price of Ulodesine Hydrochloride bulk offered by BioCryst Pharmaceuticals

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty